128 related articles for article (PubMed ID: 1688507)
1. Radioimmunotherapy in the multimodality treatment of hepatocellular carcinoma with reference to second-look resection.
Tang ZY; Liu KD; Bao YM; Lu JZ; Yu YQ; Ma ZC; Zhou XD; Yang R; Gan YH; Lin ZY
Cancer; 1990 Jan; 65(2):211-5. PubMed ID: 1688507
[TBL] [Abstract][Full Text] [Related]
2. [Multimodality treatment and two-stage resection for unresectable hepatocellular carcinoma--experimental and clinical studies].
Tang ZY
Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):2-5. PubMed ID: 2163821
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of radioimmunotherapy in the multimodality treatment of hepatocellular carcinoma (HCC)].
Li KD
Zhonghua Zhong Liu Za Zhi; 1992 Nov; 14(6):430-2. PubMed ID: 1338985
[TBL] [Abstract][Full Text] [Related]
4. Preliminary result of mixed bacterial vaccine as adjuvant treatment of hepatocellular carcinoma.
Tang ZY; Zhou HY; Zhao G; Chai LM; Zhou M; Lu JZ; Liu KD; Havas HF; Nauts HC
Med Oncol Tumor Pharmacother; 1991; 8(1):23-8. PubMed ID: 1645825
[TBL] [Abstract][Full Text] [Related]
5. Radioiodinated anti-hepatocellular carcinoma (HCC) ferritin. Targeting therapy, tumor imaging and anti-antibody response in HCC patients with hepatic arterial infusion.
Fan Z; Tang Z; Liu K; Zhou D; Lu J; Yuan A; Zhao H
J Cancer Res Clin Oncol; 1992; 118(5):371-6. PubMed ID: 1316355
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunotherapy for hepatocellular carcinoma (HCC) using 131I-anti HCC isoferritin IgG: preliminary results of experimental and clinical studies.
Liu KD; Tang ZY; Bao YM; Lu JZ; Qian F; Yuan AN; Zhao HY
Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):319-23. PubMed ID: 2537805
[TBL] [Abstract][Full Text] [Related]
7. Improved long-term survival for unresectable hepatocellular carcinoma (HCC) with a combination of surgery and intrahepatic arterial infusion of 131I-anti-HCC mAb. Phase I/II clinical trials.
Zeng ZC; Tang ZY; Liu KD; Lu JZ; Xie H; Yao Z
J Cancer Res Clin Oncol; 1998; 124(5):275-80. PubMed ID: 9645459
[TBL] [Abstract][Full Text] [Related]
8. [Radioimmunotherapy combined with chemotherapy and immunotherapy for nude mice bearing human hepatocellular carcinoma].
Bao YM
Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):245-7. PubMed ID: 2625102
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunotherapy for unresectable hepatocellular carcinoma using 131I-Hepama-1 mAb: preliminary results.
Zeng ZC; Tang ZY; Xie H; Liu KD; Lu JZ; Chai XJ; Wang GF; Yao Z; Qian JM
J Cancer Res Clin Oncol; 1993; 119(5):257-9. PubMed ID: 8382704
[TBL] [Abstract][Full Text] [Related]
10. [The experimental study of anti-human AFP variant McAb in radioimmuno-detection and radioimmuno-therapy of human hepatocellular carcinoma model in nude mice].
Liu Y; Wu MC; Qian GX
Zhonghua Wai Ke Za Zhi; 1994 Nov; 32(11):650-3. PubMed ID: 7539734
[TBL] [Abstract][Full Text] [Related]
11. Human anti-(murine Ig) antibody responses in patients with hepatocellular carcinoma receiving intrahepatic arterial 131I-labeled Hepama-1 mAb. Preliminary results and discussion.
Zeng ZC; Tang ZY; Liu KD; Lu JZ; Cai XJ; Xie H
Cancer Immunol Immunother; 1994 Nov; 39(5):332-6. PubMed ID: 7987865
[TBL] [Abstract][Full Text] [Related]
12. Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center.
Abrams RA; Pajak TF; Haulk TL; Flam M; Asbell SO
Cancer J Sci Am; 1998; 4(3):178-84. PubMed ID: 9612600
[TBL] [Abstract][Full Text] [Related]
13. Variable low dose rate irradiation (131I-anti-CEA) and integrated low dose chemotherapy in the treatment of nonresectable primary intrahepatic cholangiocarcinoma.
Stillwagon GB; Order SE; Haulk T; Herpst J; Ettinger DS; Fishman EK; Klein JL; Leichner PK
Int J Radiat Oncol Biol Phys; 1991 Nov; 21(6):1601-5. PubMed ID: 1657845
[TBL] [Abstract][Full Text] [Related]
14. Phase I clinical trial of targeted therapy using 131I-Hepama-1 mAb in patients with hepatocellular carcinoma.
Chen S; Li B; Xie H; Xu L; Niu G; Fan K; Fan Q
Cancer Biother Radiopharm; 2004 Oct; 19(5):589-600. PubMed ID: 15650451
[TBL] [Abstract][Full Text] [Related]
15. Improved survival for hepatocellular cancer with combination surgery and multimodality treatment.
Sitzmann JV; Abrams R
Ann Surg; 1993 Feb; 217(2):149-54. PubMed ID: 8382468
[TBL] [Abstract][Full Text] [Related]
16. Study on small hepatocellular carcinoma and its extension.
Tang Z; Yu Y; Zhou X; Yang B; Lin Z; Lu J; Ma Z; Liu K; Ye S; Wu Z
Chin Med Sci J; 1997 Sep; 12(3):133-8. PubMed ID: 11360621
[TBL] [Abstract][Full Text] [Related]
17. [Effect of radio-immunochemotherapy-using antiferritin antibody combined with anthracycline drugs on hepatocellular carcinoma cell].
Une Y; Sato Y; Alam S; Nagabuchi E; Hata Y; Uchino J
Gan To Kagaku Ryoho; 1993 Jan; 20(1):161-3. PubMed ID: 8380685
[No Abstract] [Full Text] [Related]
18. Downstaging followed by resection plays a role in improving prognosis of unresectable hepatocellular carcinoma.
Tang ZY; Zhou XD; Ma ZC; Wu ZQ; Fan J; Qin LX; Yu Y
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):495-8. PubMed ID: 15567731
[TBL] [Abstract][Full Text] [Related]
19. [Targeting study of human hepatocellular carcinoma (HCC) using human HCC model in nude mice].
Liu KD
Zhonghua Zhong Liu Za Zhi; 1988 Nov; 10(6):414-6. PubMed ID: 2855054
[TBL] [Abstract][Full Text] [Related]
20. Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma.
Leung WT; Lau WY; Ho S; Chan M; Leung N; Lin J; Ho KC; Metreweli C; Johnson PJ; Li AK
J Nucl Med; 1994 Aug; 35(8):1313-8. PubMed ID: 7519259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
